Global Dermatology OTC medications Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Dermatology OTC medications Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Dermatology OTC medications Market Size Growth Rate by Product
  • 1.4.2 Sun screens
  • 1.4.3 Anti-aging
  • 1.4.4 Wrinkle cream
  • 1.4.5 Acne Treatment
  • 1.4.6 others
• 1.5 Market by End User
  • 1.5.1 Global Dermatology OTC medications Market Size Growth Rate by End User
  • 1.5.2 male
  • 1.5.3 female
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Dermatology OTC medications Market Size
  • 2.1.1 Global Dermatology OTC medications Revenue 2014-2025
  • 2.1.2 Global Dermatology OTC medications Sales 2014-2025
• 2.2 Dermatology OTC medications Growth Rate by Regions
  • 2.2.1 Global Dermatology OTC medications Sales by Regions
  • 2.2.2 Global Dermatology OTC medications Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Dermatology OTC medications Sales by Manufacturers
  • 3.1.1 Dermatology OTC medications Sales by Manufacturers
  • 3.1.2 Dermatology OTC medications Sales Market Share by Manufacturers
  • 3.1.3 Global Dermatology OTC medications Market Concentration Ratio (CR5 and HHI)
• 3.2 Dermatology OTC medications Revenue by Manufacturers
  • 3.2.1 Dermatology OTC medications Revenue by Manufacturers (2014-2019)
  • 3.2.2 Dermatology OTC medications Revenue Share by Manufacturers (2014-2019)
• 3.3 Dermatology OTC medications Price by Manufacturers
• 3.4 Dermatology OTC medications Manufacturing Base Distribution, Product Types
  • 3.4.1 Dermatology OTC medications Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Dermatology OTC medications Product Type
  • 3.4.3 Date of International Manufacturers Enter into Dermatology OTC medications Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Dermatology OTC medications Sales by Product
• 4.2 Global Dermatology OTC medications Revenue by Product
• 4.3 Dermatology OTC medications Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Dermatology OTC medications Breakdown Data by End User

6 North America

• 6.1 North America Dermatology OTC medications by Countries
  • 6.1.1 North America Dermatology OTC medications Sales by Countries
  • 6.1.2 North America Dermatology OTC medications Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Dermatology OTC medications by Product
• 6.3 North America Dermatology OTC medications by End User

7 Europe

• 7.1 Europe Dermatology OTC medications by Countries
  • 7.1.1 Europe Dermatology OTC medications Sales by Countries
  • 7.1.2 Europe Dermatology OTC medications Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Dermatology OTC medications by Product
• 7.3 Europe Dermatology OTC medications by End User

8 Asia Pacific

• 8.1 Asia Pacific Dermatology OTC medications by Countries
  • 8.1.1 Asia Pacific Dermatology OTC medications Sales by Countries
  • 8.1.2 Asia Pacific Dermatology OTC medications Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Dermatology OTC medications by Product
• 8.3 Asia Pacific Dermatology OTC medications by End User

9 Central & South America

• 9.1 Central & South America Dermatology OTC medications by Countries
  • 9.1.1 Central & South America Dermatology OTC medications Sales by Countries
  • 9.1.2 Central & South America Dermatology OTC medications Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Dermatology OTC medications by Product
• 9.3 Central & South America Dermatology OTC medications by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Dermatology OTC medications by Countries
  • 10.1.1 Middle East and Africa Dermatology OTC medications Sales by Countries
  • 10.1.2 Middle East and Africa Dermatology OTC medications Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Dermatology OTC medications by Product
• 10.3 Middle East and Africa Dermatology OTC medications by End User

11 Company Profiles

• 11.1 Beiersdorf
  • 11.1.1 Beiersdorf Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Beiersdorf Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Beiersdorf Dermatology OTC medications Products Offered
  • 11.1.5 Beiersdorf Recent Development
• 11.2 Lancaster Beauty
  • 11.2.1 Lancaster Beauty Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Lancaster Beauty Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Lancaster Beauty Dermatology OTC medications Products Offered
  • 11.2.5 Lancaster Beauty Recent Development
• 11.3 loreal
  • 11.3.1 loreal Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 loreal Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 loreal Dermatology OTC medications Products Offered
  • 11.3.5 loreal Recent Development
• 11.4 Johnson & Johnson
  • 11.4.1 Johnson & Johnson Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Johnson & Johnson Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Johnson & Johnson Dermatology OTC medications Products Offered
  • 11.4.5 Johnson & Johnson Recent Development
• 11.5 Obagi Medical Products
  • 11.5.1 Obagi Medical Products Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Obagi Medical Products Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Obagi Medical Products Dermatology OTC medications Products Offered
  • 11.5.5 Obagi Medical Products Recent Development
• 11.6 Bayer
  • 11.6.1 Bayer Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Bayer Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Bayer Dermatology OTC medications Products Offered
  • 11.6.5 Bayer Recent Development
• 11.7 Shiseido
  • 11.7.1 Shiseido Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Shiseido Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Shiseido Dermatology OTC medications Products Offered
  • 11.7.5 Shiseido Recent Development
• 11.8 Amway
  • 11.8.1 Amway Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Amway Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Amway Dermatology OTC medications Products Offered
  • 11.8.5 Amway Recent Development
• 11.9 Avon Products
  • 11.9.1 Avon Products Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Avon Products Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Avon Products Dermatology OTC medications Products Offered
  • 11.9.5 Avon Products Recent Development
• 11.10 Clarins
  • 11.10.1 Clarins Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Clarins Dermatology OTC medications Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Clarins Dermatology OTC medications Products Offered
  • 11.10.5 Clarins Recent Development
• 11.11 Edgewell Personal Care
• 11.12 Lotus Herbals
• 11.13 Proctor & Gamble
• 11.14 Revlon
• 11.15 COOLA SUNCARE
• 11.16 Sebapharma
• 11.17 Clinique Laboratories
• 11.18 Sisley Paris
• 11.19 Avene

12 Future Forecast

• 12.1 Dermatology OTC medications Market Forecast by Regions
  • 12.1.1 Global Dermatology OTC medications Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Dermatology OTC medications Revenue Forecast by Regions 2019-2025
• 12.2 Dermatology OTC medications Market Forecast by Product
  • 12.2.1 Global Dermatology OTC medications Sales Forecast by Product 2019-2025
  • 12.2.2 Global Dermatology OTC medications Revenue Forecast by Product 2019-2025
• 12.3 Dermatology OTC medications Market Forecast by End User
• 12.4 North America Dermatology OTC medications Forecast
• 12.5 Europe Dermatology OTC medications Forecast
• 12.6 Asia Pacific Dermatology OTC medications Forecast
• 12.7 Central & South America Dermatology OTC medications Forecast
• 12.8 Middle East and Africa Dermatology OTC medications Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Dermatology OTC medications Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details